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Early valve repair or replacement is not generally contra-indicated in patients with infective 
endocarditis and stroke with or without intracranial hemorrhage  
 
In addition to antibiotic therapy, early surgical intervention is often required for an effective treatment 
of infective endocarditis to manage the sequelae of destruction of the valve itself and the paravalvular 
structures but the decision about whether and when surgery is necessary is complex. According to the 
most recent ESC guidelines on the management of infective endocarditis, surgical treatment using 
valve repair or replacement is not recommended within the first month in patients who suffered from 
an intracranial hemorrhage (1). The exact wording of the guidelines is the following: 
- Valve surgery may be considered in IE patients with stroke or subclinical cerebral emboli and 
residual vegetation without delay if intracranial hemorrhage has been excluded by imaging 
studies and neurological damage is not severe (ie, coma) (Class IIb; Level of Evidence B). 
- In patients with major ischemic stroke or intracranial hemorrhage, it is reasonable to delay 
valve surgery for at least 4 weeks (Class IIa; Level of Evidence B). 
 
Nevertheless, waiting for four weeks or longer may not be always the best option because some of 
those patients may develop other valve-related complications, such as uncontrolled congestive heart 
failure or systemic infection. Therefore the discussion to proceed with earlier surgery has to outweight 
the risk of the disease (progressive destruction of the valve and the adjacent structures, repetitive 
embolization) against the specific risks of cerebral damages due to the surgical treatment itself. 
In the present Japanese multi-institutional study (with all the limitations of a retrospective study 
design), Okita and colleagues were  able to demonstrate that patients who underwent valvular surgery 
within 7 days of the onset of intracerebral hemorrhage had a higher risk of hospital death and new 
perioperative cerebral complications. However, the risks of hospital death and new cerebral 
complications became lower as soon as surgery was performed more than one week after the cerebral 
event.  Due to their finding, the authors propose that shortening the intervall between diagnosis of 
cerebral hemorrhage and surgery (e.g. waiting for at least 3 weeks) may already allow to decrease the 
overall risks (2). 
The authors analyzed 568 patients, out of them 118 with non-hemorrhagic cerebral infarction and 54 
with intracranial hemorrhage. Clinical outcome was analyzed according to the timing of surgery after 
the diagnosis of the cerebral event was made. The overall mortality in the different groups ranged 
between 5.6% in the group of patients operated after a cerebral hemorrhage has happened, 7.6% in 
those patients ho suffered from non-hemorrhagic cerebral infarction) and 9.1% in those without 
cerebral events. These results are remarkable and compared very favourably with those of different 
series reported in the literature – even with appropriate antibiotic therapy and surgical intervention – 
where inhospital mortality rates up to 20% were reported.  
Of course, the authors were not able to determine the mechanisms of stroke in each individual patient, 
since there was no similar cerebral imaging protocol through all the involved institutions. However 
from other sources, it is known that the most common cause of stroke in patients with infective 
endocarditis in the modern antimicrobial era is a septic embolus resulting in ischemia, often followed 
by hemorrhagic transformation (3). In the setting of systemic embolization, another question is of 
paramunt importance, namely, that of the management of anticoagulation. The latter may increase the 
risk of an embolic infarction to convert into a hemorrhagic one. On the other hand, stopping the 
anticoagulant therapy increase the chance of recurrent embolization or valve dysfunction in patients, 
especially in those patients suffering from prosthetic valve endocarditis.  
In the most recent literature, it has been recognized that early surgery is associated with a reduction in 
the rate of embolic complications in patients who present with left-sided IE and vegetations larger than 
>10 mm.  
Since Iung found significant discrepancies between guidelines and clinical practice in patients 
suffering from acute infective endocarditis (4) – in term of undertreatment – I fully accept the 
conclusions of Okita and co-authors who recommend that valve surgery may be performed in patients 
with stroke or subclinical cerebral emboli without delay if intracranial hemorrhage has been excluded 
by imaging studies and neurological damage is not severe (ie, coma) 2). In patients with major 
cerebral ischema or hemorrhage, it is reasonable to delay valve surgery for at least 3 to 4 weeks. 
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